市場調查報告書

基因組市場:全球行業趨勢,市場佔有率,規模,增長率,機遇和未來預測(2020-2025年)

Genomics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025

出版商 IMARC Services Private Limited 商品編碼 952954
出版日期 內容資訊 英文 125 Pages
商品交期: 2-3個工作天內
價格
基因組市場:全球行業趨勢,市場佔有率,規模,增長率,機遇和未來預測(2020-2025年) Genomics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025
出版日期: 2020年07月18日內容資訊: 英文 125 Pages
簡介

在2014年至2019年之間,全球基因組市場的複合年增長率約為12%。基因組學是指對生物體脫氧核糖核酸(DNA)中發現的遺傳物質的結構,功能和遺傳的研究。它包括各種用於診斷,藥物發現,精密藥物開發和農業研究的耗材,系統,軟件和服務。用於基因組學的技術包括微陣列,測序,聚合□鏈反應(PCR),核酸提取和純化,單細胞基因組學分析,這些技術對於解決複雜的遺傳問題非常有用。有效於越來越多的基於非侵入性癌症篩查的研究是市場增長的主要驅動力之一,同時對個性化醫療的需求也在不斷增長。慢性病發病率的上升也推動了市場的增長。各種技術進步,包括基於生物技術的應用程序和測試開發,都是推動增長的因素。此外,在生物信息學領域的大規模研究與開發活動以及對下一代測序服務的需求不斷增長,有望進一步推動市場。 IMARC集團預測,未來五年全球基因組市場將繼續強勁增長。

在此報告中,我們分析了全球基因組學市場的結構和趨勢,並分析了市場的總體結構,市場規模趨勢和預測,以及按組件,應用程序,技術,最終用戶和地區劃分的詳細信息。我們正在調查趨勢,市場向心力,競爭狀況,主要公司的概況等。

第1章簡介

第2章分析範圍和方法

第3章執行摘要

第4章簡介

第5章全球基因組學市場

  • 市場概況
  • 市場規模的實際價值
  • Covid-19的影響

第6章按組件細分的市場

  • 產品
    • 主要類型
  • 服務
    • 主要類型

第7章按應用細分市場

  • 功能基因組學
  • 表觀基因組學
  • 生物標誌物發現
  • 路線分析
  • 其他

第8章按技術細分的市場

  • 序列
  • 微陣列
  • 聚合□鏈反應
  • 核酸提取純化
  • 其他

第9章按最終用戶細分市場

  • 研究中心
  • 醫院和診所
  • 製藥和生物技術公司
  • 其他

第10章按地區細分市場

  • 北美
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳大利亞
    • 印度尼西亞
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 意大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東/非洲
    • 按國家劃分的市場

第11章SWOT分析

第12章價值鏈分析

第13章波特五力分析

第14章價格指數

第15章競爭情況

  • 市場結構
  • 主要公司
  • 主要公司簡介
    • 23andMe, Inc.
    • Agilent Technologies, Inc.
    • Bayer Aktiengesellschaft
    • BGI Genomics Co. Ltd.
    • Bio-RAD Laboratories Inc.
    • Danaher Corporation
    • Illumina Inc.
    • Oxford Nanopore Technologies
    • PerkinElmer Inc.
    • Myriad Genetics Inc.
    • Roche Holding AG
    • Thermo Fisher Scientific Inc.
目錄
Product Code: SR1019K88_Report

The global genomics market grew at a CAGR of around 12% during 2014-2019. Genomics refers to the study of the structure, function and inheritance of the genetic material present in the deoxyribonucleic acid (DNA) of an organism. It addresses the intrarelationship of all genes to identify their combined influence on the overall growth and development. It involves various consumables, systems, software and services for diagnostics, drug discovery, development of precision medicine and agricultural research. Some of the technologies used for genomics include microarray, sequencing, polymerase chain reaction (PCR), nucleic acid extraction and purification and single-cell genomics analysis. These techniques are highly effective in solving complex genetic problems.

The increasing adoption of non-invasive cancer screening-based research, along with the growing demand for personalized medicines, is one of the key factors driving the growth of the market. Furthermore, the rising incidences of chronic diseases is also providing a boost to the market growth. Clinical workflows are widely being integrated with genomic data for the production of targeted and personalized medicines and for studying the growth of newborn genetic screening programs and military genomics. This, along with the growing demand for genetically modified plants and organisms in the agriculture sector, is creating a positive impact on the market growth. Various technological advancements, including the development of genomics-based apps and tests, are acting as another major growth-inducing factor. Other factors, such as extensive research and development (R&D) activities in the field of bioinformatics and the increasing demand for next-generation sequencing services, are projected to drive the market further. Looking forward, IMARC Group expects the market the global genomics market to continue its strong growth during the next five years.

Breakup by Component:

  • Products
  • Instruments and Software
  • Consumables and Reagents
  • Services
  • Core Genomics Services
  • NGS-Based Services
  • Biomarker Translation Services
  • Computational Services
  • Others

Breakup by Application:

  • Functional Genomics
  • Epigenomics
  • Biomarkers Discovery
  • Pathway Analysis
  • Others

Breakup by Technology:

  • Sequencing
  • Microarray
  • Polymerase Chain Reaction
  • Nucleic Acid Extraction and Purification
  • Others

Breakup by End-User:

  • Research Centers
  • Hospitals and Clinics
  • Pharmaceutical and Biotechnology Companies
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

  • The report has also analysed the competitive landscape of the market with some of the key players being 23andMe Inc., Agilent Technologies Inc., Bayer Aktiengesellschaft, BGI Genomics Co. Ltd., Bio-RAD Laboratories Inc., Danaher Corporation, Illumina Inc., Oxford Nanopore Technologies, PerkinElmer Inc., Myriad Genetics Inc., Roche Holding AG, Thermo Fisher Scientific Inc., etc.

Key Questions Answered in This Report:

  • How has the global genomics market performed so far and how will it perform in the coming years?
  • What are the key regional markets?
  • What has been the impact of COVID-19 on the global genomics market?
  • What is the breakup of the market based on the component?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the end-user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global genomics market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Genomics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Component

  • 6.1 Products
    • 6.1.1 Market Trends
    • 6.1.2 Major Types
      • 6.1.2.1 Instruments and Software
      • 6.1.2.2 Consumables and Reagents
    • 6.1.3 Market Forecast
  • 6.2 Services
    • 6.2.1 Market Trends
    • 6.2.2 Major Types
      • 6.2.2.1 Core Genomics Services
      • 6.2.2.2 NGS-Based Services
      • 6.2.2.3 Biomarker Translation Services
      • 6.2.2.4 Computational Services
      • 6.2.2.5 Others
    • 6.2.3 Market Forecast

7 Market Breakup by Application

  • 7.1 Functional Genomics
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Epigenomics
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Biomarkers Discovery
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Pathway Analysis
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Technology

  • 8.1 Sequencing
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Microarray
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Polymerase Chain Reaction
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Nucleic Acid Extraction and Purification
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by End-User

  • 9.1 Research Centers
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Hospitals and Clinics
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Pharmaceutical and Biotechnology Companies
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Indicators

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 23andMe, Inc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 Agilent Technologies, Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Bayer Aktiengesellschaft
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 BGI Genomics Co. Ltd.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
    • 15.3.5 Bio-RAD Laboratories Inc.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Danaher Corporation
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Illumina Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Oxford Nanopore Technologies
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 PerkinElmer Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
    • 15.3.10 Myriad Genetics Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
    • 15.3.11 Roche Holding AG
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
    • 15.3.12 Thermo Fisher Scientific Inc.
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Genomics Market: Major Drivers and Challenges
  • Figure 2: Global: Genomics Market: Sales Value (in Billion US$), 2014-2019
  • Figure 3: Global: Genomics Market: Breakup by Component (in %), 2019
  • Figure 4: Global: Genomics Market: Breakup by Application (in %), 2019
  • Figure 5: Global: Genomics Market: Breakup by Technology (in %), 2019
  • Figure 6: Global: Genomics Market: Breakup by End-User (in %), 2019
  • Figure 7: Global: Genomics Market: Breakup by Region (in %), 2019
  • Figure 8: Global: Genomics Market Forecast: Sales Value (in Billion US$), 2020-2025
  • Figure 9: Global: Genomics (Products) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 10: Global: Genomics (Products) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 11: Global: Genomics (Services) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 12: Global: Genomics (Services) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 13: Global: Genomics (Functional Genomics) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 14: Global: Genomics (Functional Genomics) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 15: Global: Genomics (Epigenomics) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 16: Global: Genomics (Epigenomics) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 17: Global: Genomics (Biomarkers Discovery) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 18: Global: Genomics (Biomarkers Discovery) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 19: Global: Genomics (Pathway Analysis) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 20: Global: Genomics (Pathway Analysis) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 21: Global: Genomics (Other Applications) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 22: Global: Genomics (Other Applications) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 23: Global: Genomics (Sequencing) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 24: Global: Genomics (Sequencing) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 25: Global: Genomics (Microarray) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 26: Global: Genomics (Microarray) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 27: Global: Genomics (Polymerase Chain Reaction) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 28: Global: Genomics (Polymerase Chain Reaction) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 29: Global: Genomics (Nucleic Acid Extraction and Purification) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 30: Global: Genomics (Nucleic Acid Extraction and Purification) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 31: Global: Genomics (Other Technologies) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 32: Global: Genomics (Other Technologies) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 33: Global: Genomics (Research Centers) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 34: Global: Genomics (Research Centers) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 35: Global: Genomics (Hospitals and Clinics) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 36: Global: Genomics (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 37: Global: Genomics (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 38: Global: Genomics (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 39: Global: Genomics (Other End-Users) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 40: Global: Genomics (Other End-Users) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 41: North America: Genomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 42: North America: Genomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 43: United States: Genomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 44: United States: Genomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 45: Canada: Genomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 46: Canada: Genomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 47: Asia Pacific: Genomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 48: Asia Pacific: Genomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 49: China: Genomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 50: China: Genomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 51: Japan: Genomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 52: Japan: Genomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 53: India: Genomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 54: India: Genomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 55: South Korea: Genomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 56: South Korea: Genomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 57: Australia: Genomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 58: Australia: Genomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 59: Indonesia: Genomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 60: Indonesia: Genomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 61: Others: Genomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 62: Others: Genomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 63: Europe: Genomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 64: Europe: Genomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 65: Germany: Genomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 66: Germany: Genomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 67: France: Genomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 68: France: Genomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 69: United Kingdom: Genomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 70: United Kingdom: Genomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 71: Italy: Genomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 72: Italy: Genomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 73: Spain: Genomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 74: Spain: Genomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 75: Russia: Genomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 76: Russia: Genomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 77: Others: Genomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 78: Others: Genomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 79: Latin America: Genomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 80: Latin America: Genomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 81: Brazil: Genomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 82: Brazil: Genomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 83: Mexico: Genomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 84: Mexico: Genomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 85: Others: Genomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 86: Others: Genomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 87: Middle East and Africa: Genomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 88: Middle East and Africa: Genomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 89: Global: Genomics Industry: SWOT Analysis
  • Figure 90: Global: Genomics Industry: Value Chain Analysis
  • Figure 91: Global: Genomics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Genomics Market: Key Industry Highlights, 2019 and 2025
  • Table 2: Global: Genomics Market Forecast: Breakup by Component (in Million US$), 2020-2025
  • Table 3: Global: Genomics Market Forecast: Breakup by Application (in Million US$), 2020-2025
  • Table 4: Global: Genomics Market Forecast: Breakup by Technology (in Million US$), 2020-2025
  • Table 5: Global: Genomics Market Forecast: Breakup by End-User (in Million US$), 2020-2025
  • Table 6: Global: Genomics Market Forecast: Breakup by Region (in Million US$), 2020-2025
  • Table 7: Global: Genomics Market Structure
  • Table 8: Global: Genomics Market: Key Players